Study on Wuffes' Joint Chew
Claim 1
By week 8, 74.19% saw improved mobility.
Claim 2
By week 8, 74.19% observed less pain.
Claim 3
By week 8, 70.97% reported reduced OA symptoms.
About
Wuffes
Wuffes was founded by devoted pet parents who believe our dogs deserve nothing but the best. Born out of a personal need for better solutions to support aging dogs, Wuffes crafts supplements with scientifically-backed ingredients, free from unnecessary fillers and harmful additives. Their mission is simple: to help pets live happier, healthier lives for as long as possible. With GMP and SQF-certified manufacturing, Wuffes ensures every chew meets rigorous quality standards and complies with FDA CVM guidelines. Trusted by over 770,000 pet parents, Wuffes is redefining pet wellness with a focus on love, science, and transparency.
What is the Wuffes Joint Chew?
Wuffes’ Joint Chew is an advanced hip and joint supplement designed to support mobility, ease discomfort, and enhance overall quality of life in dogs, particularly aging or large-breed pets experiencing joint challenges. The soft chews are formulated for daily use and are suitable for dogs over 65 lbs. Recommended dosing ranges from 1 to 2 chews per day, depending on weight, and chews are ideally fed with meals.
Wuffes' 4 Pillars of Joint Health: Protect & Support, Nourish, Soothe, and Restore, guide the formulation to deliver a comprehensive, multi-targeted approach to canine joint care.
Study design for
Wuffes
A triple-blind, randomized controlled trial was conducted to assess the effects of Wuffes Joint Chews in large-breed dogs with osteoarthritis (OA).
Study Type: Clinical trial (RCT)
Sample Size: 120 large-breed dogs aged 8–14 years
Duration: 12 weeks
Groups: Test product (Wuffes), competitor product (active control), and placebo
Blinding: Participants, veterinarians, and data analysts
Data was evaluated via visual analogue scales, orthopedic scores, and perception-based surveys at Weeks 4, 8, and 12.
Study results for
Wuffes
Across the 12-week study period, dogs receiving the Wuffes Joint Chew showed consistent improvement in mobility, comfort, and quality of life based on owner perception:
Week 8:
70.97% reported reduced OA symptoms
74.19% saw improved mobility
74.19% observed less pain
70.97% saw reduced limping
67.74% noted improved quality of life
Week 12:
77.42% reported reduced OA symptoms
61.29% observed improved mobility
64.52% saw less pain
67.74% noticed improved quality of life
The Wuffes group showed strong and consistent improvement, especially in perception-based outcomes. This reinforces the product’s real-world value for dog owners.
Benefits of Clinical Research
In the crowded pet supplement market, clinical validation is key to establishing trust. Wuffes distinguishes itself with a commitment to rigorous scientific testing. Scientific vetting ensures pet parents can rely on Wuffes to deliver safe and effective care backed by real-world outcomes.
